Stem cell therapy utilizing umbilical cord stem cells is a promising treatment for autoimmune diseases, which are caused by the immune system attacking healthy cells and tissues in the body. Stem cell therapy utilizes immature cells that have the ability to develop into different types of cells, including immune cells.
Diabetes Type 1 and 2
Umbilical stem cells have the ability to improve insulin production, sensitivity, and glucose metabolism in both type 1 and type 2 diabetes, offering a successful solution for improving the quality of life for millions of people living with this chronic condition.
Umbilical cord-derived stem cells are multipotent stem cells that have the ability to differentiate into various cell types, including hepatocytes, the main functional cells of the liver. They can also secrete a range of growth factors, cytokines, and anti-inflammatory molecules that can stimulate tissue repair and regeneration. These properties make this type of stem cell therapy an attractive therapeutic option for liver diseases.
We specialize in very successful stem cell treatments that have helped countless patients suffering from osteoarthritis in their knees, hips, shoulders, and other joints. UC-MSCs are a type of stem cell that is obtained from the Wharton’s jelly of the human umbilical cord. These cells differentiate into various cell types, including bone, cartilage, and muscle cells.
Traumatic Brain Injury
Stem cell therapy utilizing mesenchymal cells (MSCs) derived from donated umbilical cord tissue has emerged as a highly successful therapy for traumatic brain injuries outside of the United States. MSCs are multipotent stem cells found in various tissues, including umbilical cords. Umbilical mesenchymal stem cells (UMSCs) have several advantages over other sources of MSCs, including easy accessibility, no ethical concerns, and they do not provoke immune responses.
Umbilical cord-derived stem cells are a promising source of stem cells for treating pulmonary disease. These stem cells are obtained from the umbilical cord after a baby is born and are a rich source of hematopoietic stem cells, mesenchymal stem cells, and endothelial progenitor cells.
In studies, this stem cell therapy treatment has been shown to improve cardiac function and reduce myocardial infarct size in patients with CVDs. These stem cells have also been shown to promote angiogenesis (the formation of new blood vessels) and reduce inflammation in the heart.
Spinal Cord Injury
The use of UC-MSCs for the treatment of a spinal cord injury involves the injection of these cells directly into the spinal cord at the site of injury. The goal of this treatment is to promote tissue repair and regeneration, reduce inflammation, and improve functional outcomes.
Stem cell therapy utilizing umbilical derived mesenchymal stem cells (MSCs) continues to show tremendous success in the treatment of Parkinson’s Disease (PD) and various other neurodegenerative disorders. MSCs are unique in their ability to differentiate into different cell types, including neurons and glia, as well as to secrete growth factors and other signaling molecules that can help to promote nerve cell survival and repair.
Rheumatoid Arthritis (RA)
Stem cell therapy is a promising approach for treating RA, as it aims to not only reduce inflammation but also regenerate damaged tissue in the affected joints. We believe the most effective sources of stem cells for RA treatment is Wharton’s jelly derived stem cells (WJ-MSCs).
WJSCs can also be used to treat acute kidney injury, which is a sudden loss of kidney function. Acute kidney injury can occur as a result of injury, infection, or medication toxicity. WJSCs can be introduced into the bloodstream, where they can migrate to the site of injury and promote the regeneration of damaged kidney tissue. This can lead to a faster recovery and a reduced risk of long-term kidney damage.
Stem cell therapy utilizing Wharton’s jelly derived stem cells, which are derived from the umbilical cord, are now widely recognized as an effective treatment for cerebral palsy. Wharton’s jelly stem cells have several advantages over other types of stem cells, including their ability to differentiate into various types of cells, their immunomodulatory properties, and their non-existent risk of causing an immune response. These properties make them an attractive solution for treating CP.
There are several mechanisms by which umbilical cord stem cells offer therapeutic benefits in COPD. These cells have potent anti-inflammatory properties, which helps to reduce the chronic inflammation associated with COPD. By reducing inflammation, stem cells can help to protect lung tissue and improve lung function.
Mesenchymal stem cells (MSCs) derived from umbilical cord tissue are a type of stem cell that has had very positive outcomes for patients with multiple sclerosis. MSCs modulate the immune system, they have the potential to promote neuroprotection, they also secrete growth factors and cytokines that promote the differentiation and maturation of oligodendrocytes, which are cells that produce the myelin sheath.
WJ-MSCs are believed to be effective by promoting the regeneration and repair of damaged brain tissue, reducing inflammation and improving blood flow. They have the ability to differentiate into different cell types, including neurons and glial cells, which are the cells that make up the brain and spinal cord.
One way is that the use of stem cells may help to reduce inflammation in the brain, which has been linked to autism. Stem cells reduce inflammation by releasing anti-inflammatory molecules, promoting the growth of new blood vessels, and stimulating the production of new brain cells.